Breast cancer: a candidate gene approach across the estrogen metabolic pathway. - Wikidata - thesis-toulmin - TriplyDB

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

http://www.wikidata.org/entity/Q33288647

about

Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice.HSD17B1 genetic variants and hormone receptor-defined breast cancer.Apolipoprotein E Allelic Frequency Altered in Women with Early-onset Breast Cancer Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis SNP-SNP interactions discovered by logic regression explain Crohn's disease genetics.Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk.Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.Importance measures for epistatic interactions in case-parent trios.The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes.Polymorphisms in HSD17B1: Early Onset and Increased Risk of Alzheimer's Disease in Women with Down Syndrome.Estrogen-related genes and their contribution to racial differences in breast cancer risk.Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case-control studies.Peroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.Peroxisome proliferator-activated receptor gamma (PPARG) rs1801282 C>G polymorphism is associated with cancer susceptibility in asians: an updated meta-analysis.Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction.Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis.No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls.Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls.Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis.Inherited variations in the SOD and GPX gene families and cancer risk.Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy.Try113His and His139Arg polymorphisms in the microsomal epoxide hydrolase gene are not associated with risk of breast cancer.CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.Polymorphism of HSD17B1 Ser312Gly with Cancer Risk: Evidence from 66,147 Subjects.There is no relationship between SOD2 Val-16Ala polymorphism and breast cancer risk or survival.Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer.Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators Association between Val16Ala Polymorphism and Cancer Risk: Evidence from 33,098 Cases and 37,831 Controls

P2860

Q28741808-487708C4-D9A9-4EED-9A3A-68B66C7CA285 Q33675997-08A5C0A1-4806-4238-A97B-CC50928A865B Q33837788-391CA582-72E9-4877-9E06-55D74CC18CEA Q34014453-53DB1678-7B22-4241-9270-709F273A240B Q34037584-5257B50A-6988-423B-8781-D437A718A22C Q34306305-846A8128-44CB-449D-999C-BAA69323477B Q34435081-F1E650FF-5177-4CBB-B8CF-65B8F3190596 Q34446738-CABC7480-E5FC-4956-9035-1DB190D0CEED Q34460484-08F56215-EBB7-4211-803B-16CBF02C9EA4 Q34594697-33193C13-7315-4D15-93A7-D01A19AF585E Q34686832-F6EF2CB3-6CA0-464E-B3DB-BC7D5D2D4D3A Q35558999-0326A883-F058-4749-BDD8-C6C8A1D141BE Q35587188-51B8D947-3913-4D86-ADAE-9B7859B7AA6C Q35846077-F6AD015F-5403-4F85-9F9A-3D82FCD25A53 Q35972488-1696EAD7-2FCF-4CA3-8EDD-674115355003 Q36142309-9774DFA1-BD40-41D2-ADB2-C18F7FC79523 Q36182663-8E5FDA25-AC98-4CA9-ACD1-A256A00223FE Q36182783-B510C46A-5D02-4CBC-BC37-A992A02CBDAC Q36322483-170D0AAB-7B3E-47D8-90B9-A0FAB94A85C6 Q36841465-687CB1C1-EFE3-4B9F-9A1B-01E4C841C8D3 Q37662732-20536C2F-D718-4910-880E-5AF23F2CB451 Q37669261-B2C68CB4-BC80-4846-97C9-F3C141A9204C Q37669264-7D2139B4-57C5-4885-B567-25032FD25659 Q37669267-2C81D321-A452-4629-98EE-96BC28E53133 Q37669801-C8128EB7-18EA-4FE7-8F07-BBEBDED95A03 Q37976875-A5362DC4-E58A-4EC6-8598-41E583EAD071 Q38305705-E6FB352D-C64A-4E85-907C-3EEAE890E832 Q38397833-795AADF0-E642-4942-AA01-FC088BFF25A6 Q38627269-D928465B-D01B-4C36-9E84-E6A93B90C82F Q40882467-DA5A0A5F-BE65-49F9-B754-9619F70FF7BF Q42376302-AB147A3F-4725-4C9D-A2C7-2C7C44D07FCB Q47567895-FF3963E4-038A-4403-A5E7-724C1FFD8EA3 Q57568320-36C06609-9142-46A8-9AFA-6502D1934CF2 Q58770127-792B1E89-52C7-4BF6-92C2-9C5FB503860F

P2860

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

http://www.wikidata.org/entity/Q33288647

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

@ast

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

@en

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

@nl

type

label

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

@ast

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

@en

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

@nl

prefLabel

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

@ast

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

@en

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

@nl

P1433

Q33288647-DA3D7B61-69FB-4E4B-957F-4A854ED8B8FF

P1476

Q33288647-44B3A6DA-7DD1-4129-8EDB-969E6BADE2AE

P2093

Q33288647-1477CF32-D521-4A86-A7BB-23FAB4C78533

Q33288647-2F350039-B6B7-461C-A974-B5EBA55F5EC1

Q33288647-32046E9F-305C-4F2A-B304-A9EA1A230641

Q33288647-43023ED1-A29E-4EB2-A772-A2613A064341

Q33288647-5D5B30F6-6740-46FA-81EA-2DF3DE07480F

Q33288647-699E2A76-4B64-40E0-AD59-AA5D2D39A024

Q33288647-7FB2A3EC-F96B-49C9-B111-D068835C6FE9

Q33288647-81300721-4C30-4E3F-8DB8-F46161FF3C8E

Q33288647-8A841CF7-58C2-47FF-9833-EFE596C5EFEE

Q33288647-8B0FB6CC-9A5E-4128-ABD9-ACBC97B4211A

P2860

Q33288647-B6C76E2E-5153-40CF-9FC8-88567920504A

P2888

Q33288647-DF151063-3228-43D6-B9C5-C10295095E69

P304

Q33288647-8FD0CABA-300F-461C-BEE7-74AF24904E13

P31

Q33288647-C88C5768-3D9F-441F-A457-16F2231E476E

P356

Q33288647-2D85CBB9-24DD-43C5-B9A5-A8F50A7F72F7

P407

Q33288647-40E5C92D-FE0F-42A1-96A2-2F4FA71D0A83

P433

Q33288647-09748211-2D33-45DA-979C-C457D6D523E1

P478

Q33288647-8D31663F-3A7A-4355-B17E-02748A7DBA34

P50

Q33288647-02731176-7349-4307-85E6-86CBA0D66D86

Q33288647-37394B4A-498D-4599-B0EC-E853D977662B

Q33288647-7C5269F2-6982-4945-B5D7-466196F6768F

Q33288647-84A3844D-126E-480E-9047-4AF7B6D31E34

Q33288647-A42071A1-CF4D-440D-9B9B-1A46DF1FFC44

P577

Q33288647-635422B4-A3CB-4D40-8091-0B277397EB4F

P6179

Q33288647-0E1D8D51-C352-4AD1-943D-98531A7ACBE2

P698

Q33288647-9160E0BF-2FCB-40C0-9AB8-090E038B92F4

P356

S10549-007-9586-8

P1433

Breast Cancer Research and Treatment

P1476

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

@en

P2093

Beate Pesch

http://www.w3.org/2001/XMLSchema#string

Caren Vollmert

http://www.w3.org/2001/XMLSchema#string

Christian Baisch

http://www.w3.org/2001/XMLSchema#string

Christiane B Pierl

http://www.w3.org/2001/XMLSchema#string

Christina Justenhoven

http://www.w3.org/2001/XMLSchema#string

Falk Schubert

http://www.w3.org/2001/XMLSchema#string

Hermann M Bolt

http://www.w3.org/2001/XMLSchema#string

Jürgen Dippon

http://www.w3.org/2001/XMLSchema#string

Katja Ickstadt

http://www.w3.org/2001/XMLSchema#string

Michael Gilbert

http://www.w3.org/2001/XMLSchema#string

P2860

Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy.

P2888

s10549-007-9586-8

P304

137-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-007-9586-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030495385

http://www.w3.org/2001/XMLSchema#string

P698

17588204

http://www.w3.org/2001/XMLSchema#string